Immunomodulator Potential of Phyllantus Acidus Leaf Extract in Type 1 Diabetes Mellitus (T1DM) Models

Authors

Firas Khaleyla

Department of Biology, Faculty of Mathematics and Natural Sciences, Universitas Negeri Surabaya, Surabaya-60231 (Indonesia)

Nur Kuswanti

Department of Biology, Faculty of Mathematics and Natural Sciences, Universitas Negeri Surabaya, Surabaya-60231 (Indonesia)

Nur Qomariyah

Department of Biology, Faculty of Mathematics and Natural Sciences, Universitas Negeri Surabaya, Surabaya-60231 (Indonesia)

Erlix Rakhmad Purnama

Department of Biology, Faculty of Mathematics and Natural Sciences, Universitas Negeri Surabaya, Surabaya-60231 (Indonesia)

Article Information

DOI: 10.51584/IJRIAS.2026.11060034

Subject Category: Health Science

Volume/Issue: 11/6 | Page No: 336-342

Publication Timeline

Submitted: 2026-05-18

Accepted: 2026-05-23

Published: 2026-06-19

Abstract

Type 1 diabetes mellitus (T1DM) is characterized by high level of blood sugar, or hyperglycemia. The hyperglycemia condition in T1DM patients results in complication that made patients have higher chance to be infected with various infectious disease. Phyllantus acidus is a local plant usually consumed for its fruit, but other parts of the plant still saw lack of use locally. This study was aimed to examine the potential of Phyllantus acidus leaf extract to be immunomodulator in T1DM-induced animal model. Leaves of P. acidus was extracted using maceration and its content was analyzed using LC-HRMS. T1DM was induced in mice models using alloxan. P. acidus leaf extract was given for 10 days and in the 11th day, mice were injected with Staphylococcus aureus to induce macrophage activity. Phagocytic activity of peritoneal macrophages was evaluated from Giemsa-stained smear, while spleen was prepared into 4 µm histological section using paraffin method and stained with hematoxylin-eosin, then examined of its structure. Results showed that phagocytic activity increased significantly in mice treated with extract compared to negative control, however extract did not significantly improve spleen structure in T1DM mice compared to normal control. The secondary metabolites identified in extract including sorbic acid, L (-)-Pipecolinic acid, and Υ-Aminobutyric acid (GABA). Metabolites contained in the extract possibly affects the innate response of the mice models, however the short period of treatment resulted in insignificant effect to adaptive immunity. Thus, it can be concluded that P. acidus leaf extract was able to increase innate immune response in T1DM mice models, however further study is needed to examine longer period of treatment.

Keywords

Phyllantus acidus, diabetes, innate immunity, macrophage, spleen

Downloads

References

1. International Diabetes Federation (2021). Diabetes Atlas. IDF. [Google Scholar] [Crossref]

2. Roep, B. O., Thomaidou, S., van Tienhoven, R., & Zaldumbide, A. (2021). Type 1 diabetes mellitus as a disease of the β-cell (do not blame the immune system?). Nature Reviews Endocrinology, 17(3), 150–161. [Google Scholar] [Crossref]

3. Milionis, C., & Milioni, S. O. (2020). A brief analysis and hypotheses about the risk of COVID-19 for people with type 1 and type 2 diabetes mellitus. Journal of Diabetes & Metabolic Disorders, 19(2), 2035–2039. [Google Scholar] [Crossref]

4. Shang, L., Shao, M., Guo, Q., Shi, J., Zhao, Y., Xiaokereti, J., & Tang, B. (2020). Diabetes mellitus is associated with severe infection and mortality in patients with COVID-19: A systematic review and meta-analysis. Archives of Medical Research, 51(7), 700–709. [Google Scholar] [Crossref]

5. Carey, I. M., Critchley, J. A., DeWilde, S., Harris, T., Hosking, F. J., & Cook, D. G. (2018). Risk of infection in type 1 and type 2 diabetes compared with the general population: A matched cohort study. Diabetes Care, 41(3), 513–521. [Google Scholar] [Crossref]

6. Janssen, A. W. M., Stienstra, R., Jaeger, M., van Gool, A. J., Joosten, L. A. B., Netea, M. G., Riksen, N. P., & Tack, C. J. (2021). Understanding the increased risk of infections in diabetes: Innate and adaptive immune responses in type 1 diabetes. Metabolism, 121, 154795. [Google Scholar] [Crossref]

7. Eibl, N., Spatz, M., Fischer, G. F., Mayr, W. R., Samstag, A., Wolf, H. M., Schernthaner, G., & Eibl, M. M. (2002). Impaired primary immune response in type-1 diabetes: Results from a controlled vaccination study. Clinical Immunology, 103(3), 249–259. [Google Scholar] [Crossref]

8. Handayani, N., Wahyuono, S., Hertiani, T., & Murwanti, R. (2018). Uji aktivitas fagositosis makrofag ekstrak etanol daun suji (Dracaena angustifolia (Medik) Roxb.) secara in vitro. Pharmaceutical and Medical Journal, 1(1). [In Indonesian]. [Google Scholar] [Crossref]

9. Kapila, V., Wehrle, C. J., & Tuma, F. (2023). Physiology, spleen. In StatPearls. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK537307/ [Google Scholar] [Crossref]

10. Jantan, I., Haque, M. A., Ilangkovan, M., & Arshad, L. (2019). An insight into the modulatory effects and mechanisms of action of Phyllanthus species and their bioactive metabolites on the immune system. Frontiers in Pharmacology, 10, 878. [Google Scholar] [Crossref]

11. Chakraborty, R., Biplab, D., Devanna, N., & Sen, S. (2012). Antiinflammatory, antinociceptive and antioxidant activities of Phyllanthus acidus L. extracts. Asian Pacific Journal of Tropical Biomedicine, 2(Suppl. 2), S953–S961. [Google Scholar] [Crossref]

12. Ibrahim, K. E., Al-Mutary, M. G., Bakhiet, A. O., & Khan, H. A. (2018). Histopathology of the liver, kidney, and spleen of mice exposed to gold nanoparticles. Molecules, 23(8), 1848. [Google Scholar] [Crossref]

13. Jafar, N., Edriss, H., & Nugent, K. (2016). The effect of short-term hyperglycemia on the innate immune system. The American Journal of the Medical Sciences, 351(2), 201–211. [Google Scholar] [Crossref]

14. Feng, X. J., Chen, W. X., Ni, X. Y., Little, P. J., Xu, S. W., Tang, L. Q., & Weng, J. P. (2021). Metformin, macrophage dysfunction and atherosclerosis. Frontiers in Immunology, 12, 682853. [Google Scholar] [Crossref]

15. Janeway, C., Paul, C., Travers, M., Walport, M., & Shlomchik, M. (2001). Immunobiology (5th ed.). Garland Science. [Google Scholar] [Crossref]

16. Luo, Z. F., Fang, X. L., Shu, G., Wang, S. B., Zhu, X. T., Gao, P., Chen, L. L., Chen, C. Y., Xi, Q. Y., Zhang, Y. L., & Jiang, Q. Y. (2011). Sorbic acid improves growth performance and regulates insulin-like growth factor system gene expression in swine. Journal of Animal Science, 89(8), 2356–2364. [Google Scholar] [Crossref]

17. Siddiqui, Z., Khan, M. I, Badruddeen, B, Akhtar, J., Ahmad, M. (2022). Multifunctional Role of Phyllanthus Acidus L. As a Therapeutic Agent for Management of Diabetes and Associated Complications: A Review. Biomedical and Pharmacology Journal,15(4), 1821-1831. [Google Scholar] [Crossref]

18. Oktaviona, E. E. P., Qomariyah, N., & Khaleyla, F. (2023). Hepatoprotective Activity of Phyllanthus acidus L. Leaf Extract in Type 2 Diabetes Mellitus Mice. LenteraBio : Berkala Ilmiah Biologi , 12(3), 381–388. [Google Scholar] [Crossref]

19. Chigurupati, S. (2020). Antioxidant and antidiabetic properties of Phyllanthus acidus (L.) Skeels ethanolic seed extract. International Food Research Journal, 27(4), 775-782. [Google Scholar] [Crossref]

20. Nemes, D., Kovács, R., Nagy, F., Tóth, Z., Herczegh, P., Borbás, A., Kelemen, V., Pfliegler, W. P., Rebenku, I., Hajdu, P. B., Fehér, P., Ujhelyi, Z., Fenyvesi, F., Váradi, J., Vecsernyés, V., & Bácskay, I. (2020). Comparative biocompatibility and antimicrobial studies of sorbic acid derivates. European Journal of Pharmaceutical Sciences, 143, 105162. [Google Scholar] [Crossref]

21. Spadaro, O., Camell, C. D., Bosurgi, L., Nguyen, K. Y., Youm, Y. H., Rothlin, C. V., & Dixit, V. D. (2017). IGF1 shapes macrophage activation in response to immunometabolic challenge. Cell Reports, 19(2), 225–234. [Google Scholar] [Crossref]

22. Luo, L., Cai, Y., Jiang, Y., Gong, Y., Cai, C., Lai, D., Jin, X., Guan,Z., & Qiu, Q. (2023). Pipecolic acid mitigates ferroptosis in diabetic retinopathy by regulating GPX4-YAP signaling. Biomedicine & Pharmacotherapy, 169, 115895. [Google Scholar] [Crossref]

23. Ngo, D. H., & Vo, T. S. (2019). An updated review on pharmaceutical properties of gamma-aminobutyric acid. Molecules, 24, 2678. [Google Scholar] [Crossref]

24. Richard, C., Lewis, E. D., Goruk, S., Wadge, E., Curtis, J. M., Jacobs, R. L., & Field, C. J. (2017). Feeding a mixture of choline forms to lactating dams improves the development of the immune system in Sprague-Dawley rat offspring. Nutrients, 9, 567. [Google Scholar] [Crossref]

25. Sikalidis, A. K. (2015). Amino acids and immune response: A role for cysteine, glutamine, phenylalanine, tryptophan and arginine in T-cell function and cancer? Pathology and Oncology Research, 21(1), 9–17. [Google Scholar] [Crossref]

26. Shivaprasad, H. N., Kharya, M. D., Rana, A. C., & Mohan, S. (2006). Preliminary immunomodulatory activities of aqueous extract of Terminalia chebula. Pharmaceutical Biology, 44, 32–34. [Google Scholar] [Crossref]

Metrics

Views & Downloads

Similar Articles